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Abstract 
Practice Problem: At a small community facility in Los Angeles County, there was a reporting 
rate of hospital-acquired Clostridium difficile cases that was higher than both state and national 
benchmarks. 
PICOT: The PICOT question that guided this project was: In acute care patients aged 18-90, 
does not retesting for CDI for at least seven days compared to retesting in less than seven days 
reduce the incidence of false positive CDI tests during the first seven days of the hospital stay?   
Evidence: The evidence demonstrates that if patients are tested initially for Clostridium difficile 
and then retested seven days after, the rate of hospital-acquired Clostridium difficile decreases. 
Intervention: A facility policy was implemented to restrict CDI testing until seven or more days 
after the initial test. 
Outcome: A total of 19 patients were initially tested for Clostridium difficile. Medical personnel 
determined that only two of those patients needed a second test, which was done after seven 
days. There were no hospital-acquired cases during the project period, unlike during the same 
time frame the previous year. 
Conclusion: The project results supported the literature showing that waiting seven days before 
performing a repeat Clostridium difficile test can reduce the number of hospital-acquired 
Clostridium difficile cases by reducing false positives. This was beneficial to the hospital which 
was able to reduce costs, and improve the quality of the care. 
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A Policy Change to Reduce Hospital-Acquired Clostridium Difficile Infection Rates:   
A Quality Improvement Project 
The purpose of this project was to implement a policy change that would reduce the 
number of patients being misdiagnosed with hospital-acquired Clostridium difficile infection 
(CDI). Infections caused by the bacteria can cost hospitals as much as $3.2 billion annually 
(Surawicz et al., 2013). This paper describes the significance and the framework of the problem, 
synthesize and interpret the related literature, define practice recommendations, describe the 
project setting, report the project mission and objectives, discuss the project implementation and 
evaluation, and explain its dissemination. 
Significance of the Practice Problem 
Clostridium difficile is a gram-positive bacterium (Block et al., 2018). It is a leading 
cause of gastrointestinal illness. About 500,000 patients contract CDI each year, resulting in 
30,000 deaths in the United States (Lee, 2018). According to Mao et al. (2018), Caucasian 
patients have a higher risk for CDI when compared to African-American, Hispanic, Asian and 
Native American patients. Infection rates have increased steadily since the year 2000, mostly 
affecting the elderly (Pechal, et al., 2016). Eighty percent off patients who die from CDI are 65 
and over; one out of every 11 patients who are aged 65 or over will die if they contract the 
infection (Pechal, et al., 2016). Patients who have CDI have been known to have long lengths of 
stay can be increased by as much as six or seven days (Chopra et al., 2015). According to Zhang 
et al. (2016), the cost per hospital-acquired CDI case is $34,157, CDI case management and 
CDI-attributable costs per case are $42,316. However, the length of stay, and the costs associated 
with a complex infection, are not the only concerns, as patients who contract CDI are twice as 
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likely to be readmitted to the hospital (Chopra et al., 2015). Readmission costs for CDI can be as 
high as $13,000. 
Due to the costs of this preventable infection, the Centers for Medicare Medicaid 
Services (CMS) mandates hospitals to report CDI rates. The CDI data is calculated by the 
Standardized Infection Ratio (SIR) as required by the National Healthcare Safety Network 
(CDC, 2018). The SIR is computed by dividing the number of observed CDI infections by the 
number of predicted infections. If the SIR is >1, then there were more CDI cases than predicted, 
based on the 2015 national aggregate data (California Health & Human Services Agency, 2017). 
The goal is to have less than that (CDC, 2018). According to Pimentel, et al. (2018), “CMS is 
seeking to shed light on this type of preventable patient harm and raising the stakes by putting 
financial penalties and a hospital’s public reputation at risk” (p.414).  
Patients or their families may further damage a hospital’s reputation by suing the 
hospitals because of CDI. If the patient or family can prove that medical negligence was 
involved, then they have a case (Boeschen, n.d.). In one lawsuit where a patient died due to CDI, 
the facility had to pay $218,500 (Waldsmith, n.d.).  
Reducing CDI rates, hospitals will improve patients’ quality of life. Lowering hospital-
acquired CDI will decrease length of stay, death, and suffering from symptoms and time spent in 
isolation (Block et al., 2018). Patients’ family members who visit will be at a decreased risk of 
contracting CDI (Barker et al., 2017). And hospitals will reduce the potential for costly CDI-
related hospital stays and CMS penalties. 
Framework of the Problem 
For the purpose of this project, the Kurt Lewin Change Theory was utilized (Cumbler et 
al., 2013). This model has been used previously for this type of project (Shingler-Nace et al., 
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2019). It has three steps: unfreezing, change, and refreezing (Cumbler, et al., 2013).  The 
unfreezing phase consists of convincing people to change their current pattern of behavior 
(Cumbler et al., 2013). For the current project, this step involved implementing an evidence-
based policy so that CDI testing cannot be repeated within a seven-day period, and educating the 
staff about the new policy.  
Before this policy change, patients who came into the hospital with diarrhea were tested 
initially for CDI. Then the test happens again within a day or two; most of these patients would 
have had a Clostridium difficile test orders three times within a three-day period. As described in 
the Themes from Literature section of this paper such repeated testing is not warranted because it 
increases false positives. Thus, the practica site’s Handling Patients with Clostridium Difficile 
Infections Policy was changed under the section that states, “Testing will be performed using 
EIA.” A statement was added that if a patient has been tested once, they will not be retested until 
seven days have passed. This policy can be reviewed in Appendix A. 
In the change phase, people are convinced that the new way is better (Cumbler et al., 
2013). The nurses at the practica site were shown a brief PowerPoint presentation so that they 
understood the severity of the CDI testing problem, and why the change was necessary. Then, in 
the refreezing phase, the change becomes a new and accepted process (Cumbler et al., 2013). 
The refreezing step was deemed complete when the staff realized that they are not being 
reminded to stop reordering the CDI testing. Ongoing monitoring of CDI testing at the facility in 
question was conducted by the project manager, charge nurses and the infection preventionist. 
PICOT Question 
The PICOT question for this project was: In acute care patients aged 18-90, does not 
retesting for CDI for at least seven days compared to retesting in less than seven days reduce the 
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incidence of false positive CDI tests during the first seven days of the hospital stay? The 
population was adult inpatients on the intensive care unit, telemetry unit and medical surgical 
unit of an acute care hospital.  Any patients aged 18 and over were eligible for inclusion. 
Pediatric patients admitted to the medical surgical unit were excluded. The intervention was 
intended to reduce the number and frequency of repeat CDI test so that patients exhibiting 
symptoms of CDI (such as diarrhea or abdominal pain) were tested once, and then only retested 
once more after seven days in the hospital. The comparison intervention was patients admitted 
one year prior to the intervention period who had an initial test for CDI and were then retested 
prior to the seven-day period. 
The purpose of the study was to compare the number of positive CDI tests in the 
intervention group (those patients who have repeat testing after seven days) to the number of 
positive CDI tests in the group who underwent earlier or more frequent repeat testing. The 
facility uses the Clostridium difficile A & B test, which gives two results: an antigen and a toxin. 
A patient is considered positive for CDI if the toxin test comes back positive. Patients who were 
tested once and had either a negative result or a positive antigen result, and were then retested 
within three days and have a positive result were deemed “false positive.” The desired project 
outcome was for there to be a reduced number of false positive results for CDI testing, in an 
attempt to save the hospital thousands of dollars and avoid treating patients for CDI who do not 
truly need it during the first seven days of their hospital stay. 
Literature Search Strategy 
A literature review was performed to answer the PICOT question. In acute care patients 
aged 18-90 (P), does not retesting for CDI for at least seven days (I) compared to retesting in less 
than seven days (C) reduce the incidence of false positive CDI tests (O) during the first seven 
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days of the hospital stay (T)?  The first search was performed on the American Journal of 
Gastroenterology website. The PICOT question was used as the search phrase. The search 
resulted in one article. The following search was completed on the Biomed Central Journal. The 
search term used was “repeat testing for Clostridium Difficile”. There were 10 results, and 
abstracts of the 10 results were reviewed. One article was selected; the other nine results were 
abstracts from presentations, which are not appropriate for this project.  
After these two initial searches, a search was conducted on the Infection Control and 
Hospital Epidemiology website. The search was limited to open access articles with the date 
range of 2000-2019, it produced 27 results. All 27 abstracts were reviewed. One article was 
selected, as this article focuses on repeat CDI testing.   
On the PubMed database, the search phrase “repeat testing for Clostridium difficile” was 
used. This resulted in 72 articles, and all abstracts were reviewed. There were 18 articles 
pertinent to the topic. Finally, on Search USA, the search term “repeat testing for Clostridium 
difficile” was used, which produced 17 articles. After the abstracts were reviewed five articles 
were selected. The search results can be viewed as a PRISMA model in Figure 11. 
Literature Search Results and Evaluation 
A total of 25 articles were selected based on the inclusion criteria.  Six of the articles 
reviewed were clinical practice guidelines. Each of the guidelines was reviewed using the 
AGREE tool (Brouwers, et al., 2016). In addition, there were 17 primary research articles and 
two systematic reviews evaluated using the STROBE model (von Elm et al., 2008).  
The evidence table for the primary research articles can be viewed in Appendix B. The 
evidence table for the systematic reviews can be examined in Appendix C. The articles were 
analyzed for level of evidence and quality ratings using the method described by Dearholt and 
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Dang (2012). There are seven levels of evidence, ranging from Level I, which is considered to be 
a systematic review, to Level VII, which is an expert opinion or consensus statement. The 
diagram in Figure 12 shows all seven levels of evidence. 
Overall, the evidence of the 25 articles reviewed for this project can be rated a Level IV. 
This rating was given because six of the primary research articles achieved a Level IV evidence 
rating, but three of the primary research articles only received a VI evidence rating, which 
brought the overall evidence rating down. In order for the group of articles as a whole to achieve 
a higher evidence rating, three more primary research articles should have received an evidence 
rating of Level I. 
In regards to quality, the 25 articles reviewed achieved a B for overall quality. This was 
the case because six of the articles were determined to be A quality, and eight of the 25 articles 
were rated an A or B for quality. If at least 12 of the articles achieved a rating of A or B, then the 
whole body of evidence reviewed for this project could have achieved a quality rating of A. 
Despite only five articles having an A quality, the level of evidence of the group of articles 
warranted the practice change. 
Themes from the Literature 
The consensus among the six clinical practice guidelines reviewed is that CDI testing 
should only be done seven days after the initial CDI test. Bobenchick et al.’s (2019) systematic 
review (which earned an evidence Level I and a quality grade of A; see Appendix C) considered 
six practice guidelines for CDI testing and advocated for retesting only after seven days, 
specifically because retesting sooner can cause false positive CDI test results. Indeed, repeat 
testing in less than seven days leads to inappropriate treatment because negative results are more 
likely to be changed to false positives (Aichinger et al., 2008; Buckel et al., 2015; Gade & 
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Turrett, 2009; Surawicz et al., 2013). Khanna et al. (2012) found that 1,759 patients who were 
tested twice in the same day, 42 of the results converted to positive. Furthermore, Luo et al. 
(2013) found that of 2,949 repeated tests, 135 of them converted to positive in six days or less. 
The increase in hospital-acquired CDI cases may be due to cases being misdiagnosed 
from over testing (Grien et al., 2014). This may be because of the sensitivity of the CDI toxin A 
& B test to result in a false positive (Green et al., 2014; Toltzis et al., 2012). However, Cardona 
and Rand (2008) found that when they tested patients every day for six days, the patients 
consistently tested either positive or negative each time, lending support to the conclusions that 
early repeated testing is not only unnecessary, it is not cost effective (Depshande et al., 2010; 
Mohan et al., 2006; Mostafa et al., 2018). 
Hospitals can avoid such false positives, or changes from a negative to a positive result, 
by limiting CDI testing. Kamboj et al. (2018) showed that out of 31 hospitals, 15 of them have a 
policy in place restricting repeat CDI testing within seven days. Other studies showed that a hard 
stop could be added to a facility’s medical charting software to prevent CDI retests. For example, 
both Quan (2018) and Block et al. (2018) did experimental studies showing that a hard stop in 
the electronic medical record reduced repeat test orders significantly. In addition, Madden et al. 
(2018), which was also an experimental study that earned an A rating for quality, demonstrated a 
41% reduction in repeat testing. 
Regardless of the clear benefits attributed to less frequent CDI testing, some healthcare 
staff believe that ordering multiple CDI testing is necessary. Both Zilberg et al. (2011) and 
Blanco et al. (2018) explain that many clinicians order multiple CDI test after the initial is 
negative. This mindset seems to be an attempt to overcome the testing sensitivity; however, it 
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increases the risk of false positives. The majority of the articles reviewed for this project clearly 
state that repeat testing should be restricted to five to seven days after the initial test. 
Practice Recommendations 
Using the available evidence, it is clear that if repeat testing for CDI is restricted to being 
performed seven days or more after the initial testing, then the risk of creating false positives for 
hospital-acquired CDI is reduced. All of the clinical practice guidelines reviewed indicated that 
repeat CDI testing should not be performed until seven days after the initial test. In various 
primary research studies the same result was also discovered. 
Project Setting 
The setting for this project was a 117-bed acute care hospital in Southern California. The 
hospital has been in practice for over 50 years. In 2011, the hospital was purchased by the Avanti 
company making it part of a four-hospital system in Los Angeles County. In 2018, the hospital 
was purchased by the Pipeline Company. There are over 270 staff members and 200 physicians. 
The hospital is accredited by the Joint Commission for primary stroke, the lab and the facility. 
The units consist of an emergency department, an intensive care unit, medical-surgical unit, and 
telemetry unit. The patient population is 66% Hispanic, 13% Caucasian, 13% Asian, 6% African 
American, 1% American Indian, and 1% Pacific Islander or other. The top five admitting 
diagnoses are: abdominal pain, hyperglycemia, heart failure, chronic obstructive pulmonary 
disease and altered level of consciousness.  
The facility’s mission statement is “to provide affordable, high-quality healthcare 
services to our communities with consistency and compassion.” The facility vision statement is 
“each life is a priority.” There are three organizational charts. At the top are the head members of 
the Pipeline Company. Below them are the heads of the Avanti Company. The last one is the 
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hospital organizational chart. The members at the top are Governing Board, the Chief Medical  
Officer,  the Chief Executive Officer and the Chief Nursing Officer. Below them are the various 
departmental directors such as: Lab, Radiology, Dietary, Housekeeping, Cardiopulmonary, 
Infection Control, Quality, Emergency Management, Education, and Nursing Directors. The 
culture at this facility is very diverse. There is staff from a plethora of backgrounds including: 
African American, Caucasian, Filipino, Korean and others. 
The check sheet method (see Appendix D) was utilized to assess the need for a change 
regarding CDI. During this assessment it was determined that the facility had seven cases in 
2017, three cases in 2018, and 11 cases in 2019. In Figure 13 is a comparison of the SIR for the 
hospital, the state benchmark and the national benchmark. The CMS (2019) uses the 
winsorization process to evaluate the results of hospital acquired infections. Based on this 
process the hospital is below the fifth percentile for CDI for the time period of January 2017 to 
December 2018.  
The key stakeholders at the hospital are: the Chief Executive Officer, Chief Nursing 
Officer, Infection Preventionist, Infection Control Chairman, Chairman of the Governing Board, 
the Chief Medical Officer, Chief of Medicine and a controller.   
They are very concerned about this issue. After hearing some ideas on how to address 
this problem, support was offered. This project was carried out with the assistance of the 
infection preventionist, educator, and the nursing supervisors.  
A SWOT analysis was conducted on 10/4/2019; the results are in Appendix E. Some of 
the strengths identified were the support from the key stakeholders and the preceptor. The 
opportunities to address the CDI problem were the strong leadership structure, the new hospital 
ownership and the heavily involved medical staff. One the main weakness was the restrictions of 
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the electronic medical record. At this time, a hard stop to prevent multiple CDI orders could not 
be put in place. One of the main threats to the project success is the high nursing turnover rate. 
Project Overview 
The mission of this project was to reduce the risk of false positive CDI results. The vision 
of this project was to reduce the number of hospital-acquired Clostridium difficile cases. The 
project’s mission aligns with the mission of the facility, as the mission’s focus is on high-quality 
care.  The short-term objective was to change the policy so that patients could not be retested 
within seven days. One long-term objective was to educate the staff and monitor to ensure that 
repeat orders are not being done before a 7-day timeframe. Another long-term objective was to 
decrease costs related to CDI. One example of how this project could help the hospital achieve 
its mission of high-quality care is that it could help provide appropriate care for patients, so that 
hospital-acquired CDI does not occur. One possible risk or unintended consequence was the 
resistance of nurses to the policy change.  As an incentive, the facility’s staff recognition 
program was utilized for nurses who are routinely following the new CDI testing policy. 
Project Plan 
The change model used for this project was the PDCA Cycle (Johnson, 2016; see 
Appendix F). The PDCA stands for plan, do, check, act. This model was chosen because it was a 
good fit for the project. It has been used for similar projects like this (Block et al., 2018). This is 
also the standard model that the facility utilizes, so the staff was familiar with it.  
Plan 
The plan was to create the new policy. The current infection control manual was 
reviewed, and the policy was revised to include that a patient tested for CDI will not be retested 
within seven days of the first test.  The policy was changed with the assistance of the Infection 
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Preventionist. Barriers to this change were not expected, because the key stakeholders were very 
concerned about this topic. The form in Appendix G contains the evidenced-based practice 
council approval letter and Appendix H contains the signatures of approval from the 
stakeholders.  
Do 
The do step involved educating the staff and applying the policy. The ARCS instructional 
design model was utilized (see Appendix I). This model focuses on getting the nurses attention, 
showing them the relevant evidence, giving them confidence and raising their satisfaction. A 
meeting was held with the educator to discuss the education plan for the change. The education 
was conducted with the assistance of the infection preventionist, educator and the nursing 
supervisors. Once 80% of the nursing staff had been educated on the new policy, the policy went 
into effect on 2/27/20. Once the policy was in effect, ongoing monitoring of patients with CDI 
testing was conducted. The monitoring was completed with the assistance of the charge nurses. 
A barrier to this step was the high nurse turnover at the facility. In an effort to combat this, the 
policy was added to the nursing orientation educational material. This way all new incoming 
nurses were aware of the policy. The nurses signed an attestation form that they are 
knowledgeable of the policy change.  See Appendix I for the attestation form. 
Check 
In the check step, the information technology department was requested to create a daily 
report that tracks patients with the C-diff A & B test ordered. The nurses taking care of these 
patients were reminded that repeat testing was not permitted until after seven days. A barrier to 
this step was that nursing did not have access to request a hard stop in the electronic medical 
record to stop any repeat orders. Thus, nurses who order a repeat test were, reeducated.  
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Act 
The act step included asking the staff their opinions on the change and reviewing the 
compliance data as well as the CDI rates. The evaluation of the project was conducted from 
5/15/20-5/31/20. The schedule for the project is located in Appendix J. The main resources 
needed were the assistance of at least two of the departmental leaders as well as the nursing staff. 
My role as project manager was to lead the project. The nurse educator, infection preventionist, 
and the project manager worked together to educate the staff. Interprofessional collaboration was 
needed for this project to be a success.  
The budget was based on the situation currently at the practica site. Staffing costs were 
calculated based on the base rate per position and included 57 staff registered nurses $19,767.60, 
14 charge nurses $6,684.72, five nursing supervisors $2,803.20, one nurse educator $320, and 
one infection preventionist, $224. Supplies included the following: paper, pen, binder, and 
laminating paper which totaled $361.25. The costs of electricity and the computer are not 
included as they are normally in use in the facility. Services and Statistician were not used. The 
budget is shown in Table 1.  
Project Evaluation Plan 
The project was evaluated by comparing the number of CDI cases before implementation 
to those after implementation. A comparison of the pre-implementation to postimplementation 
SIR was completed, and a t-test comparing the two numbers was calculated to determine if any 
change was significant. These data were based on NHSN criteria. 
The hospital’s IT department created a report that identified patients who were tested for 
CDI. A review of the number of patients who were repeat tested was performed. The repeat 
testing percentages were compared and a significance test was calculated. A table was then 
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developed showing those patients’ demographics, including age, gender, and ethnicity. The units 
the patients were on was included. The emergency department, pediatrics and operating room 
were not included. The patients’ medical record numbers, names, and birthdays were not 
included to prevent a violation of privacy of health information.  
To get a complete picture of the situation before and after implementation, other outcome 
measures and financial measures were compared: CDI mortalities, length of stay and 
readmissions. In addition, process measures, including staff education and compliance, were 
assessed during the project. 
Appendix K includes the categories for the data variables. All data were collected onsite 
and entered into Microsoft Excel in a private office to protect patient privacy. A CDI Detection 
and Surveillance Assessment was conducted (Minnesota Department of Health, 2018). This tool 
asks questions about the repeat testing (see Appendix L). If there are multiple “yes” answers on 
the tool, then the change was successful. 
Project Evaluation Results 
The data collection took place after 57 (86%) members of the nursing staff were educated 
by the project manager, nurse educator and infection preventionist. The implementation period 
for the project was from February 27, 2020 to April 20, 2020. During that time period, a total of 
19 patients had CDI testing ordered.  
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Figure 1. Of those 19 patients 13(68%) were male and 6(32%) female participants. 
 
Figure 2. The racial demographics of the group were 8 (42%) were White, 2 (11%) were Asian, 
and 5 (26%) identified themselves as another race. Participants’ ages varied widely, with a 
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Figure 3. Five percent of patients were between the ages of 30-39 and 5% between the ages of 
40-49. 11% were between the ages of 50-59 and 11% between the ages of 90-99. 21% were 
between the ages of 60-69 and 21% between the ages of 70-79;and  26% between the ages of 80-
89.  
 
Figure 4. This bar graph displays what units the participants were on when they were tested for 
CDI, 68% of the patients were in the Intensive Care Unit, 26% were in the Telemetry unit and 
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Figure 5. Participants were admitted from two locations, 12 (63%) from nursing homes and 7 
(37%) of the patients were from their own home. 
 Data on CDI testing from the implementation period (February 27, 2020 to April 20, 
2020) was compared to the same time period in the previous year by the infection preventionist 
and the project manager. From February 27, 2019 to April 20, 2019 there were 63 CDI tests 
ordered by the hospital compared to 21 tests during the implementation period. A t-test was 
conducted using Excel 2007 to compare the hospital-acquired CDI test results between pre-
implementation (2) and  post-implementation (0) time periods. A two tailed distribution was used 
with a two-sample unequal variance. The calculated p-value=0.16. The alpha for this project was 
set at > 0.05, so this result was not statistically significant. 
 Only two participants had repeat testing performed during the intervention period. Both 
tests were done appropriately, seven days from the initial test, and they both were negative. The 
cost of each CDI test performed was $134.36. In 2019 during the time period in question, 
$8,464.68 was spent on CDI tests, while in 2020 only $2,821.56 was spent by the hospital, 
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Figure 6. 
The number of CDI cases during the implementation period was zero, compared with two 
cases in the same period during 2019. Because the typical hospital-acquired CDI cases typically 
costs $15,397, and the 2019 time period had two cases; the project resulted in a savings of 
$30,794 in 2020. Also, in 2020, the SIR was zero, compared with one from the previous year. 
The comparison in the SIR rates is located in Figure 7. For both time periods, there were no CDI 
readmissions and no mortalities. 
The nursing staff compliance with the project was 100%. The CDI Detection and 
Surveillance Assessment was used for evaluation by the infection preventionist and the student, 
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Figure 7. This bar graph shows the SIR rate at the hospital during the 2019 pre-intervention 
period, the California state average, the national average, and the hospital’s SIR rate during the 
2020 intervention period. 
 
 
Figure 8. Displayed here are the initial results for the 19 participants, 84% were negative, and 
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Figure 9. Repeated Test Results. Of the 19 patients initially tested for CDI, only two were 
deemed necessary to retest within the seven-day window. Both patients had a negative antigen 
and negative toxin result. 
 
Figure 10. 
    Discussions and Implications 
The project asked: In acute care patients aged 18-90, does not retesting for CDI for at 













CLOSTRIDIUM DIFFICLE RETESTING 23 
positive CDI tests during the first seven days of the hospital stay? Our reported findings suggest 
that retesting patients only after seven days does reduce the incidence of false positive CDI 
results. Upon initial testing, (3) 16% of patients were admitted with CDI, and 84% did not have 
CDI.  
This project was a successful attempt to change the practice, as 86% of the nursing staff 
was educated on, and 100% were compliant with, the new policy. One of the reasons for this 
achievement was due to the collaboration of the team. Nurses were educated by the educator, 
infection preventionist and the project manager. The charge nurses were the champions on the 
units. Only once during the project period was a CDI test ordered that did not follow the new 
policy. This occurrence was made by a registry nurse, but the order was cancelled by the charge 
nurse of the unit. As no specimen was collected, this did not result in a policy violation.  
The project results aligned with the recent literature, that repeat CDI tests should not be 
performed until at least seven days have passed since the initial test. There were no positive 
retests, no mortalities due to CDI, and no readmissions. Possible reasons for these results include 
the low number of participants and the limited time frame. The low number of patients was most 
likely due to the COVID-19 pandemic. The pandemic led to a stay-at-home order, which reduced 
the number of patients coming to the facility. 
The findings of this project are relevant to practice. The hospital had fewer cases of 
hospital-acquired CDI during the project period, which demonstrates increased quality of patient 
care. Because hospital CDI data is required to be reported and is posted online, patients will be 
able to see the improvement, and the hospital will gain more reimbursement from CMS. The 
project also resulted in a total costs savings of $36,437.12, due to reduction in number of tests 
ordered and no hospital-acquired CDI cases. Due to the success of this project, it should be 
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replicated, but with a longer time period of at least six months. This project should also be 
carried out at a hospital with a larger patient census. 
Plans for Dissemination 
The results of the project were shared with the key stakeholders, the CEO, CNO, 
Infectious Disease Physician, Chief of Medicine, Chief Medical Officer and the Chairman of the 
Governing Board. A PowerPoint presentation with the key points of the project was presented at 
Infection Control Committee.  A handout with highlights of the project was posted in the break 
areas and discussed at nursing department meetings. The results were shared with infection 
control departments from the other hospitals within the system, as well as with the nursing 
homes, assisted living facilities and senior centers in the area.  
In addition to local dissemination, the abstract will be submitted to the 16th World 
Congress on Infection Prevention and Control which will take place online on September 16, 
2020. The Association for Professionals in Infection Control and Epidemiology was cancelled 
for 2020; however, an abstract will be submitted for 2021. Results will also be submitted for 
publication in an appropriate journal such as, Prevention Strategist or American Journal of 
Infection Control. The project will be archived in SOAR@USA and the Virginia Henderson 
Library. 
Conclusion 
The intention of this paper was to describe each step of a scholarly project that would 
result in a reduction of false positive, hospital acquired CDI. Hospital-acquired CDI is 
tremendously costly as well as detrimental for the patients, their families and the facility. The 
project, which was a policy change implemented using the PDCA Cycle, was successful in 
reducing both the number of repeated tests, and the number of false positive CDI tests, reported 
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within seven days of symptomatic patients’ admission to the hospital. Findings from this project 
have been shared with the appropriate parties.  
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Table 1 
Project Budget 
EXPENSES  REVENUE  
Direct   Billing  
Salary and benefits 
57 RNs 
14 Charge RNs 
5 Nursing Supervisors 
1 Educator 









Paper, Pen, Binder, 
Laminating paper 
361.25 Institutional budget support 0 
Services N/A Expected savings from reduced 
testing 
1,209.24+ 
Statistician N/ Expected savings from reduced 
hospital acquired CDI 
15,397+ 
  Expected savings from reduced 
length of stay 
7123+ 
  Expected savings from reduced 
readmissions 
13,000+ 
Indirect    
Overhead    
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Total Expenses 30,160.77 Total Revenue 36,729.24+ 
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Figure 12. Levels of evidence, adapted from Dearholt, S. L., & Dang, D. (2012). Johns Hopkins 























Level I : Systematic Review, Meta Analysis,  
Evidenceased Guidelined
Level II: Randomized Control Trial
Level III: Quasi-Experimental Study
Level IV: Case Control, Cohort, or Correlational 
Study
Level V: Systematic Review of 
Descriptive/Qualitative Study
Level VI: Descriptive/Qualitative Study
Level VII: Opinion of Authorities, Expert 
Committee Report




Figure13. Comparison of hospital, state, and national CDI Rates for 2019, prior to the 
intervention.  
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Appendix A 
Handling Patients with Clostridium Difficile Infections Policy 
PURPOSE: 
To prevent transmission of Clostridium difficile from infected patients to other patients during hospitalization. 
PROCEDURE: 
A. For patients admitted to the hospital with the diagnosis of Clostridium difficile gastroenteritis or rule out C. difficile gastroenteritis, or patients 
with diarrhea, the patient should be placed in Contact Isolation for Clostridium difficile which includes adherence to the following: 
1. Patient should be placed in a private room.  An order from attending physician for contact isolation is not needed prior to placing the patient 
in isolation. Also, place a sign on the alcohol hand sanitizer inside the room indicating “Do not use, Wash with soap and water” 
2. A stool specimen should be collected as soon as possible after admission and sent to laboratory for C. difficile testing. 
  3. Utilize proper personal protective equipment (PPE) including gowns and gloves prior to entering the room to prevent direct physical contact 
with infected patient, patient care equipment and environmental surfaces within the patient room 
 4. Contaminated linens should be handled with gloves and bagged before taken out of the room. 
  5. Disposable, dedicated patient care equipment such as thermometer, stethoscope and blood pressure cuff should be used whenever possible.  
If non-disposable equipment is used, it should be placed in a plastic bag before removal from room by Central Service or other Ancillary 
Departments, or should be disinfected with bleach-containing wipes prior to removal. 
    6. Patient care equipment (IV Poles, Oxygen Flow Meters, assistive devices    such as walkers, wheel chairs, etc.) are to remain in the room 
until patient is discharged or until discontinuation of isolation.  Such equipment must be disinfected with bleach germicidal prior to use. 
  7. All equipment from Clostridium difficile rooms are to be cleaned with bleach containing germicidal. 
  8. Patients who develop diarrhea during their hospitalization and Clostridium difficile gastroenteritis is suspected should be immediately 
placed in contact isolation prior to testing for Clostridium difficile.  If test results are negative, isolation can be discontinued. 
Admission Screening For Clostridium difficile:  
1. On admission all patients are screened for C. difficile based on screening criteria below, as part of the admission process.  Patients admitted 
with diarrhea, or had diarrhea within three days of admission, should be tested for C. difficile as soon after admission as possible as indicated 
above. , by collecting a stool specimen.  For patients admitted through the Emergency Department, a specimen may be collected there if 
feasible. 
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2. For patients who meets one criteria each in both category 1 and category 2, patient will be determined as high risk and will be placed on 
contact isolation and then a stool specimen will be collected if developed loose or watery diarrhea and sent to laboratory for c. difficile 
testing.   
3. This testing will only apply to admission screening and specimen will be tested per screening protocol order.  There is no need for an order 
from the attending physician.    
4. Testing is to be done using the following guidelines:  
Patient has at least one item in Category 1AND at least one item in Category 2: 
Category 1:  
a) □History of C. difficile infection. 
b) □Broad spectrum antibiotic use within last 90 days 
c) □Extended period in LTAC, SNF or Nursing Home 
d) □Is seriously immunocompromised       
e) □Had recent GI or GU surgery 
f) □Taking medication to reduce stomach acid 
AND 
 
Category 2:    
a) □Fever 
b) □High WBC (>11,000) on admission 
c) □Abdominal pain 
 
For these patients with suspected C. difficile infections (High Risk), the patient will be placed in Contact isolation precautions.  if the stool 
was found negative for C. difficile, isolation will be discontinued. 
5. Testing will be performed using EIA. Patients who have been tested, will not have a repeat test performed within 7 days.  Results are 
interpreted as: 
6.  
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Ag Toxin  Interpretation 
Negative Negative Patient negative, Treatment not 
indicated 
Positive  Negative Indicates likely colonization, Treatment 
not usually indicated.  Patient may 
benefit from Probiotics 
Positive Positive 
 
If clinically correlated, treatment is 
indicated per guidelines 
 
TREATMENT and discontinuation of isolation: 
A. for patients with Clostridium difficile infection, treatment with Flagyl, P.O. Vancomycin or other anti C. diff medications may be instituted by 
the Physician. 
B. Isolation should continue as long as symptoms (diarrhea: more than 2-3 bowel movements daily and loose/watery stools) persist.  
C. Patients with no symptoms of active infections for at least 48 hours may be taken out of isolation upon an order from the treating physician.  No 
testing is needed to discontinue isolation for asymptomatic patients (based on CDC guidelines).  
Procedure for disinfection of room: 
A. Upon getting an order for discontinuation of isolation of a Clostridium difficile infected patient or if such patient is discharged or transferred, 
Nursing will inform Environmental Services Department, by phone, of the need for room cleaning post C. difficile isolation. Nursing staff will 
not remove the isolation sign or the “Wash Hands with soap and water” sign from the room.  
B. Nursing should remove all equipment from room prior to arrival of EVS staff.  Equipment should be bagged in designated bags before removal 
from room into soiled utility room.   
C. EVS staff assigned to clean the room will bring with them bleach germicidal solution, along with other normal cleaning supplies and 
equipment.  
D. EVS Staff will clean the room utilizing “Terminal Cleaning of Isolation Room” procedures.  This procedure must include changing the privacy 
curtain. 
E. After normal cleaning, all surfaces in room and bed will be wiped with bleach germicidal.   This step is to destroy any Clostridium difficult 
spores that may be on these surfaces. 
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F. Following the completion of the room cleaning, EVS staff will remove the isolation signs and will document the cleaning process in the 
designated Clostridium Difficile Log at the Nursing Station. 
G Equipment taken to the soiled utility room will be picked-up by Central Services Department staff and will be cleaned using bleach containing 
germicidal. 
If room cleaning is to be done while the patient is still in the room, i.e. following discontinuation of isolation, all the above steps will be followed 
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      Appendix B 





















include any specific 























683 patients An evaluation of 
repeat testing was 
performed. The p 
value was 
calculated. 
There is no value 
in repeat testing for 
CDI within a seven 
day period. 
There are no 
diagnostic gains 
for repeat CDI 
testing, this 
should not be 
routinely done. 
Of the 605 who initially tested negative, 20 
of them tested positive on the repeat. 




34 staff This qualitative 
study was an 
overview of 
healthcare workers 
opinions about an 
EMR hard stop on 
repeat CDI testing 





the high sensitivity 
of CDI tests, 
patients who have 
tested negative 
should not be 
retested within 5-7 
days. 
There is a gap in 
the knowledge 
that doctors and 
nurses should 
not retest 
patients for CDI 
within 5-7 days. 
Nurses believe that patients need to be tested 
at least twice to be sure of the results. 
Physicians believe that patients require 





N/A  This study 
compared CDI rates 




infection ratios were 
compared. 
Staff must be 
properly educated 
on CDI testing. 
Having a 
computerized 
support tool to 
stop repeat 




CDI cases decreased by 40% Hospital saved 
$60,000. SIR decreased from 1.2 to 0.87. 
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cases. 




222 tests This study 
compared amount of 
tests and CDI cases 
pre and post 
implementation. 
Descriptive 
statistics, z test and 
x2 tests were used. 
Making sure that 
nurses are well 
educated about 








testing, leads to 
a lower amount 
of repeat CDI 
test being 
ordered. 
Inappropriate testing is linked to 
inappropriate treatment. Staff should be 






3,112 patients Repeat CDI testing 
was done on days 
two and three for 
patients who were 
initially negative. 
Chi square and 
Yates correction 
were used. 
There is no value 
to repeat testing 
within the first 





tests within two 
days and 
limiting it to 
over seven days. 
Of the repeated tests 0.9% were positive on 
the same day as the initial, and 10.6% were 





268 patients This was a 
retrospective study 
of CDI testing. The 
positive predictive 
value and negative 
predictive values 
were calculated. 
Patients are often 
tested more than 
needed for CDI. 
At least 16% of 
CDI testing is 
not necessary. 
After the initial test, 11.9% tested positive 
on the first repeat, 4.1% tested positive on 
the second repeat, and less than one percent 
on the fourth repeat. 




14,875 tests Created a policy 
where the lab would 
reject repeat CDI 
tests within 7 days. 
Used Fischer’s exact 
test and t test. 
Multiple studies 
have demonstrated 
that repeat testing 
within days yields 
positive results.  
Repeat CDI 
testing leads to 
false-positive 
results. 
After the initial test, 1% of tests were 
negative on the repeat within 7 days.  




20,836 tests Reviewed multiple 




Wilcoxon rank sum 
and Kruskal-Wallis 
tests. 
The incidence and 
severity of CDI is 
complicated by 
high rates of 
misdiagnosis due 
to multiple tests 
being ordered. 
There was a 
48% reduction 
in testing when a 
policy was 
created for the 
lab department 
to cancel all 
repeat CDI tests 
within a week. 
Hospital acquired CDI testing rates were 
less the EIA test when compared with the 
PCR and 2T tests. 51% of hospitals use EIA 
tests. 
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31 hospitals Evaluation of testing 
practices at 31 
hospitals. Tests used 
were the Pearson 
coefficient and the 
Kruskal-Wallis. 
Over testing for 
CDI can over 
diagnose carriers 
of CDI as CDI 
cases. 










longer length of 
stay. 
Fifteen of the hospitals had a policy on not 
repeating testing within seven days. 




1956 patients This study 
compared results of 
repeat testing CDI 
within 7 days and 






CDI testing is very 
sensitive. 
Repeat testing 
for CDI has a 
low yield, and 
patients with an 
initial negative 
test should not 
be routinely 
retested. 
42 patients who were initially negative, were 
repeated on the same day as a positive. 




7,336 patients This study 
compared CDI 
repeat testing pre 
and post 
implementation 
after CPOE alert for 
CDI repeat test for 
physicians was in 
place. 
CDI toxin testing 
is highly sensitive 




















A pop up in the 
electronic medical 
record would alert 
when the CDI test 
was reordered. 
Testing rates were 
compares with t 













41% reduction in CDI testing, 31% fewer 
hospital acquired CDI events 
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Evaluation of CDI 
tests was completed. 
Even though the 
EIA CDI test is 
sensitive, it does 
not require repeat 
usage. 




Of the 78 patients who had a CDI test 
repeated within seven days only one 





20,526 tests A chart review of 





Due to the low 
sensitivity of CDI 
testing clinicians 
seem to 
consistently order   
repeat testing. 
CDI repeat 
testing should be 
limited to after 
seven days. 
Of the 970 tests which were repeated within 
7 days, 4.5% of them converted to positive. 
For the converted patients there was a 
correlation between this and extended length 
of stay. 




N/A An automated 
computerized 
physician order 
entry verification to 
enforce no testing if 
the patient 
previously had a test 
within 7 days. 
CDI rates have 
increased partially 






A hard stop 
prompt would 
appear if a 
physician 
attempted to 
reorder a CDI 
test within 7 
days of the first.  
CDI testing reordered within 7 days 
decreased by 64%. Hospital acquired CDI 
decreased by 54%. 




112 Comparison of 
amount of true 




done using the x2 
test and the 
Wilcoxon 2 sample 
test. 
In previous study, 
only 2/3 of 
positive CDI 
results were true 
positives. 
Physicians have a 
tendency to over 
order CDI testing 




of the CDI test 
is 64% 





1,351,156 The x2 test was used 
to compare the rates 
pre and post 
implementation. The 
Poisson model was 
used to indentify 
factors associated 
CDI testing 
sensitivity is a 
possible factor 









high CDI rates. 
50.6% of CDI cases were hospital acquired 
due to testing sensitivity. 
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Appendix C 
Summary of Systematic Reviews (SR)  
Citation  Quality 
Grade 
Question Search Strategy Inclusion/ 
Exclusion Criteria 







A “repeated testing for 
Clostridium difficile” 
Pubmed N/A Patient should only 
be retested within 7 
days in an epidemic 
situation. 
Testing for a cure should 
not be done as 60% of 
patients remain positive 
after treatment. 
Testing should not 
be repeated due to  
an increase in 
diagnostic yield of 
specimens. 
Deshpand
e et al., 
2010 
C “repeated testing for 
Clostridium difficile” 
Search USA N/A Limiting number of 
stool specimens sent 
will reduce false 
positives. 
Clinicians order multiple 
CDI testing  
EIA is the preferred 
testing method. 
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       Appendix D 
 




Q1 2017 Q2 2017 Q3 2017 Q4 2017 Q1 2018 Q2 2018 Q 3 2018 Q4 2018 Totals 
HA CDI 2 2 2 1 1 1 1 0 11 
Total 2 2 2 1 1 1 1 0 11 
 
Defect Type Q1 2019 Q2 2019 Q3 2019 Q4 2019 Totals 
HA CDI 2 4 3 2 11 























Internal Forces (project) External Forced (organization or environment) 
Strengths Opportunities 
• Preceptor support 
• Key stakeholder support 
• Assistance from infection preventionist 
and nurse educator 
• Supporting evidence 
• Strong leadership structure and support 
• New ownership 
• Strong and involved medical staff 
Weaknesses Threats 
• Manual data collection due to 
restrictions in EMR system 
• The high nursing turnover rate 
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  Appendix F 
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        Appendix G 
        EPRC Letter 
University of St. Augustine for Health Sciences 
Doctor of Nursing Practice Program 
Evidence-Based Practice Review Council  
1 University Blvd. 




Dear Nia Hidalgo, 
 
Your proposal titled A Policy Change to Reduce Clostridium Difficile Infection Rates has been reviewed by the University of St. Augustine for 
Health Sciences Doctor of Nursing Practice Evidence-Based Practice Review Council (EPRC) and determined to: 
 
___ meet the requirements for research as defined in the Federal Register. You must make adjustments to the proposal to reflect the DNP program 
requirements and resubmit for additional review. Work closely with your faculty member during this process. 
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_X__ not meet the requirements for research as defined in the Federal Register. Your proposal reflects an evidence-based practice change project. 
The proposal must be implemented as submitted (changes are not permitted). You may proceed to obtain approvals from the facility where the 
project will be implemented. Implementation may not begin until you are notified in writing by faculty that you may implement the project.   
 
Questions regarding the USAHS approval process should be addressed to Dr. Douglas Turner at DTurner@usa.edu. Questions regarding the facility 
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        Appendix H 









Attention  Relevance Confidence Satisfaction 
Hearing the financial 
facts about CDI will 
gain the nurses 
attention. 
A portion of the 
nurses annual raise is 
dependent on hospital 
acquired conditions 
for their home units. 
This displays the 
relevance of the issue 
to each individual 
nurse. 
The nurses should 
have confidence in 
making sure the test is 
not repeated within 
seven days. They will 




will be used to reward 


























































































































































Meet with preceptor X                        
Get to know site/staff X X                       
Select topic  X                       
Form PICO Statement  X                       
Literature Review  X                       
Review with Infection 
Preventionist 
 X                       
Review with preceptor   X                      
Develop project 
proposal 
  X                      
Submit for school 
proposal 
        X                
Revise as needed and 
resubmit 
         X               
Submit for practica 
site approval 
          X              
Formulate education 
plan with educator 
           X             
Begin education             X            
Begin implementation              X           
Round with nursing 
staff 
              X X X        
Ask for feedback                 X        
Adjust plan if needed              X X X X X X X     
Data Collection                         
Project Evaluation                     X X X X 
                         
                         
                         
                         
                         
                         




Project Evaluation Table 
 
Variable Type of Data Category Statistical Test 
Code number Nominal N/A Standard Percentage 
Gender Nominal N/A Standard Percentage 
Ethnicity Nominal N/A Standard Percentage 
Age Interval N/A Standard Percentage 
Hospital Unit Interval N/A Standard Percentage 
CDI Initial Testing Nominal Process T test 
CDI Repeat Testing 
within 7 days 
Nominal Process Standard Percentage 
CDI Mortalities Nominal Outcome, Financial Standard Percentage 
CDI Readmissions Nominal Outcome, Financial Standard Percentage 
CDI Length of Stay Nominal Outcome, Financial Standard Percentage 
SIR Rates Interval Outcome, Financial NHSN Module 
Staff Education Unk Process, Sustainability Standard Percentage 
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     Appendix L 
Data Collection Tool for Evaluation : CDI Detection and Surveillance Assessment 
Testing policies followed that: Yes No N/A 
Reject formed stools X   
Submit one stool specimen for initial CDI testing X   
Avoid serial testing when initial test is negative X   
Do not test asymptomatic patients X   
Do not conduct repeat testing during the same episode of diarrhea for 
confirmed CDI patients 
X   
Retest only if CDI symptoms continue or recur after 10 days of treatment   X 
Do not perform “tests of cure” post treatment   X 
Avoid serial testing of patients X   
 
Assessment Questions Yes No N/A 
Facility-wide CDI surveillance is in place X   
Facility applies standardized National Health Care Safety Network 
(NHSN) CDI surveillance definitions 
X   
Facility has a process in place to review and analyze CDI surveillance 
data 
X   
CDI surveillance data is disseminated to facility senior leadership, 
physicians, patient care staff, and environmental services department, 
pharmacy, and laboratory staff 
X   




Clinical Assessment Questions Yes No N/A 
Clinical staff are trained to recognize the signs and symptoms of CDI X   
Appropriate health care providers are trained to obtain specimens for 
laboratory testing of patients suspected of having CDI 
X   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
